{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:23:19Z","timestamp":1790137399945,"version":"4.0.1"},"reference-count":43,"publisher":"American Association for Cancer Research (AACR)","issue":"20","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Wnt\/\u03b2-catenin\/T-cell factor (Tcf) pathway is aberrantly up-regulated in the majority of colorectal cancers (CRC) and hepatoblastomas due to either an APC or \u03b2-catenin gene mutation. We constructed synthetic promoters, T and TE, which contain tandem repeats of a Tcf responsive element without and with the human 4F2 gene intronic enhancer, respectively. Although the T and TE promoters showed higher transcriptional activity than a control promoter in all CRC and hepatoblastoma cell lines tested, with low activities in most other tumor cell lines, the level of transcription varied considerably among the CRC and hepatoblastoma cell lines. In some CRC cell lines, the TE promoter displayed higher levels of transcription than even the human CMVIE promoter. In those CRC cells, the APC gene mutations were located within a small segment between the first and second 20-amino-acid repeats in the mutation cluster region of the APC protein. We created a transcriptionally targeted oncolytic herpes simplex virus vector (bM24-TE) in which replication is driven by the TE promoter. This vector efficiently and specifically replicated in and killed tumor cells with strong \u03b2-catenin\/Tcf signaling. Intratumoral injection of bM24-TE significantly reduced the growth of highly \u03b2-catenin active SW480 CRC tumors and induced a complete response in half of them, whereas it had no effect on the growth of \u03b2-catenin-inactive A549 tumors. Our results suggest that a transcriptionally regulated oncolytic herpes vector targeting \u03b2-catenin\/Tcf signal is very efficacious against CRC tumors carrying an APC gene mutation between the first and second 20-amino-acid repeats. (Cancer Res 2006; 66(20): 10127-35)<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-2744","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T05:42:10Z","timestamp":1161150130000},"page":"10127-10135","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Effective Treatment of Tumors with Strong \u03b2-Catenin\/T-Cell Factor Activity by Transcriptionally Targeted Oncolytic Herpes Simplex Virus Vector"],"prefix":"10.1158","volume":"66","author":[{"given":"Toshihiko","family":"Kuroda","sequence":"first","affiliation":[{"name":"Molecular Neurosurgery Laboratory, Department of Neurosurgery, Massachusetts General Hospital\/Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel D.","family":"Rabkin","sequence":"additional","affiliation":[{"name":"Molecular Neurosurgery Laboratory, Department of Neurosurgery, Massachusetts General Hospital\/Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Martuza","sequence":"additional","affiliation":[{"name":"Molecular Neurosurgery Laboratory, Department of Neurosurgery, Massachusetts General Hospital\/Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,10,17]]},"reference":[{"key":"2022061622274478300_B1","doi-asserted-by":"crossref","unstructured":"Polakis P. Wnt signaling and cancer. Genes Dev\u20082000; 14: 1837\u201351.","DOI":"10.1101\/gad.14.15.1837"},{"key":"2022061622274478300_B2","doi-asserted-by":"crossref","unstructured":"Pandur P, Lasche M, Eisenberg LM, Kuhl M. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature\u20082002; 418: 636\u201341.","DOI":"10.1038\/nature00921"},{"key":"2022061622274478300_B3","doi-asserted-by":"crossref","unstructured":"Garcia-Castro MI, Marcelle C, Bronner-Fraser M. Ectodermal Wnt function as a neural crest inducer. Science\u20082002; 297: 848\u201351.","DOI":"10.1126\/science.1070824"},{"key":"2022061622274478300_B4","doi-asserted-by":"crossref","unstructured":"Gregorieff A, Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev\u20082005; 19: 877\u201390.","DOI":"10.1101\/gad.1295405"},{"key":"2022061622274478300_B5","doi-asserted-by":"crossref","unstructured":"Veeman MT, Axelrod JD, Moon RT. A second canon. Functions and mechanisms of \u03b2-catenin-independent Wnt signaling. Dev Cell\u20082003; 5: 367\u201377.","DOI":"10.1016\/S1534-5807(03)00266-1"},{"key":"2022061622274478300_B6","doi-asserted-by":"crossref","unstructured":"Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3\u03b2 to the APC-\u03b2-catenin complex and regulation of complex assembly. Science\u20081996; 272: 1023\u20136.","DOI":"10.1126\/science.272.5264.1023"},{"key":"2022061622274478300_B7","doi-asserted-by":"crossref","unstructured":"Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. Serine phosphorylation-regulated ubiquitination and degradation of \u03b2-catenin. J Biol Chem\u20081997; 272: 24735\u20138.","DOI":"10.1074\/jbc.272.40.24735"},{"key":"2022061622274478300_B8","doi-asserted-by":"crossref","unstructured":"Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. \u03b2-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J\u20081997; 16: 3797\u2013804.","DOI":"10.1093\/emboj\/16.13.3797"},{"key":"2022061622274478300_B9","doi-asserted-by":"crossref","unstructured":"Morin PJ, Sparks AB, Korinek V, et al. Activation of \u03b2-catenin-Tcf signaling in colon cancer by mutations in \u03b2-catenin or APC. Science\u20081997; 275: 1787\u201390.","DOI":"10.1126\/science.275.5307.1787"},{"key":"2022061622274478300_B10","doi-asserted-by":"crossref","unstructured":"Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a \u03b2-catenin-Tcf complex in APC\u2212\/\u2212 colon carcinoma. Science\u20081997; 275: 1784\u20137.","DOI":"10.1126\/science.275.5307.1784"},{"key":"2022061622274478300_B11","doi-asserted-by":"crossref","unstructured":"Behrens J, Jerchow BA, Wurtele M, et al. Functional interaction of an axin homolog, conductin, with \u03b2-catenin, APC, and GSK3\u03b2. Science\u20081998; 280: 596\u20139.","DOI":"10.1126\/science.280.5363.596"},{"key":"2022061622274478300_B12","unstructured":"Rubinfeld B, Albert I, Porfiri E, Munemitsu S, Polakis P. Loss of \u03b2-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res\u20081997; 57: 4624\u201330."},{"key":"2022061622274478300_B13","doi-asserted-by":"crossref","unstructured":"Nagase H, Nakamura Y. Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat\u20081993; 2: 425\u201334.","DOI":"10.1002\/humu.1380020602"},{"key":"2022061622274478300_B14","unstructured":"Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC\/\u03b2-catenin\/Tcf pathway in colorectal cancer. Cancer Res\u20081998; 58: 1130\u20134."},{"key":"2022061622274478300_B15","doi-asserted-by":"crossref","unstructured":"Jeng YM, Wu MZ, Mao TL, Chang MH, Hsu HC. Somatic mutations of \u03b2-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma. Cancer Lett\u20082000; 152: 45\u201351.","DOI":"10.1016\/S0304-3835(99)00433-4"},{"key":"2022061622274478300_B16","unstructured":"Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the \u03b2-catenin gene. Cancer Res\u20081999; 59: 269\u201373."},{"key":"2022061622274478300_B17","doi-asserted-by":"crossref","unstructured":"Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G, Buendia MA. Activation of \u03b2-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene\u20082000; 19: 498\u2013504.","DOI":"10.1038\/sj.onc.1203356"},{"key":"2022061622274478300_B18","doi-asserted-by":"crossref","unstructured":"Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature\u20082005; 434: 843\u201350.","DOI":"10.1038\/nature03319"},{"key":"2022061622274478300_B19","unstructured":"Chen RH, McCormick F. Selective targeting to the hyperactive \u03b2-catenin\/T-cell factor pathway in colon cancer cells. Cancer Res\u20082001; 61: 4445\u20139."},{"key":"2022061622274478300_B20","doi-asserted-by":"crossref","unstructured":"Brunori M, Malerba M, Kashiwazaki H, Iggo R. Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway. J Virol\u20082001; 75: 2857\u201365.","DOI":"10.1128\/JVI.75.6.2857-2865.2001"},{"key":"2022061622274478300_B21","doi-asserted-by":"crossref","unstructured":"Kwong KY, Zou Y, Day CP, Hung MC. The suppression of colon cancer cell growth in nude mice by targeting \u03b2-catenin\/TCF pathway. Oncogene\u20082002; 21: 8340\u20136.","DOI":"10.1038\/sj.onc.1206050"},{"key":"2022061622274478300_B22","doi-asserted-by":"crossref","unstructured":"Miyatake SI, Tani S, Feigenbaum F, et al. Hepatoma-specific antitumor activity of an albumin enhancer\/promoter regulated herpes simplex virus in vivo. Gene Ther\u20081999; 6: 564\u201372.","DOI":"10.1038\/sj.gt.3300861"},{"key":"2022061622274478300_B23","unstructured":"Yamamura H, Hashio M, Noguchi M, et al. Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors. Cancer Res\u20082001; 61: 3969\u201377."},{"key":"2022061622274478300_B24","doi-asserted-by":"crossref","unstructured":"Miyatake S, Iyer A, Martuza RL, Rabkin SD. Transcriptional targeting of herpes simplex virus for cell-specific replication. J Virol\u20081997; 71: 5124\u201332.","DOI":"10.1128\/jvi.71.7.5124-5132.1997"},{"key":"2022061622274478300_B25","doi-asserted-by":"crossref","unstructured":"Mineta T, Rabkin SD, Yazaki T, Hunter WD, Martuza RL. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med\u20081995; 1: 938\u201343.","DOI":"10.1038\/nm0995-938"},{"key":"2022061622274478300_B26","doi-asserted-by":"crossref","unstructured":"Post DE, Fulci G, Chiocca EA, Van Meir EG. Replicative oncolytic herpes simplex viruses in combination cancer therapies. Curr Gene Ther\u20082004; 4: 41\u201351.","DOI":"10.2174\/1566523044577988"},{"key":"2022061622274478300_B27","doi-asserted-by":"crossref","unstructured":"DeLuca NA, McCarthy AM, Schaffer PA. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol\u20081985; 56: 558\u201370.","DOI":"10.1128\/jvi.56.2.558-570.1985"},{"key":"2022061622274478300_B28","doi-asserted-by":"crossref","unstructured":"de La Coste A, Romagnolo B, Billuart P, et al. Somatic mutations of the \u03b2-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A\u20081998; 95: 8847\u201351.","DOI":"10.1073\/pnas.95.15.8847"},{"key":"2022061622274478300_B29","doi-asserted-by":"crossref","unstructured":"Rowan AJ, Bodmer WF. Introduction of a myc reporter tag to improve the quality of mutation detection using the protein truncation test. Hum Mutat\u20081997; 9: 172\u20136.","DOI":"10.1002\/(SICI)1098-1004(1997)9:2<172::AID-HUMU10>3.0.CO;2-#"},{"key":"2022061622274478300_B30","doi-asserted-by":"crossref","unstructured":"Rowan AJ, Lamlum H, Ilyas M, et al. APC mutations in sporadic colorectal tumors: A mutational \u201chotspot\u201d and interdependence of the \u201ctwo hits.\u201d Proc Natl Acad Sci U S A\u20082000; 97: 3352\u20137.","DOI":"10.1073\/pnas.97.7.3352"},{"key":"2022061622274478300_B31","doi-asserted-by":"crossref","unstructured":"Goldstein DJ, Weller SK. Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant. J Virol\u20081988; 62: 196\u2013205.","DOI":"10.1128\/jvi.62.1.196-205.1988"},{"key":"2022061622274478300_B32","doi-asserted-by":"crossref","unstructured":"Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A\u20081992; 89: 5547\u201351.","DOI":"10.1073\/pnas.89.12.5547"},{"key":"2022061622274478300_B33","doi-asserted-by":"crossref","unstructured":"Karpinski BA, Yang LH, Cacheris P, Morle GD, Leiden JM. The first intron of the 4F2 heavy-chain gene contains a transcriptional enhancer element that binds multiple nuclear proteins. Mol Cell Biol\u20081989; 9: 2588\u201397.","DOI":"10.1128\/MCB.9.6.2588"},{"key":"2022061622274478300_B34","doi-asserted-by":"crossref","unstructured":"Goodall J, Martinozzi S, Dexter TJ, et al. Brn-2 expression controls melanoma proliferation and is directly regulated by \u03b2-catenin. Mol Cell Biol\u20082004; 24: 2915\u201322.","DOI":"10.1128\/MCB.24.7.2915-2922.2004"},{"key":"2022061622274478300_B35","doi-asserted-by":"crossref","unstructured":"Lipinski KS, Djeha HA, Gawn J, et al. Optimization of a synthetic \u03b2-catenin-dependent promoter for tumor-specific cancer gene therapy. Mol Ther\u20082004; 10: 150\u201361.","DOI":"10.1016\/j.ymthe.2004.03.021"},{"key":"2022061622274478300_B36","unstructured":"Mineta T, Rabkin SD, Martuza RL. Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res\u20081994; 54: 3963\u20136."},{"key":"2022061622274478300_B37","doi-asserted-by":"crossref","unstructured":"Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of \u03b2-catenin by genetic defects in melanoma cell lines. Science\u20081997; 275: 1790\u20132.","DOI":"10.1126\/science.275.5307.1790"},{"key":"2022061622274478300_B38","doi-asserted-by":"crossref","unstructured":"Malerba M, Daeffler L, Rommelaere J, Iggo RD. Replicating parvoviruses that target colon cancer cells. J Virol\u20082003; 77: 6683\u201391.","DOI":"10.1128\/JVI.77.12.6683-6691.2003"},{"key":"2022061622274478300_B39","doi-asserted-by":"crossref","unstructured":"Homicsko K, Lukashev A, Iggo RD. RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer. Cancer Res\u20082005; 65: 6882\u201390.","DOI":"10.1158\/0008-5472.CAN-05-0309"},{"key":"2022061622274478300_B40","doi-asserted-by":"crossref","unstructured":"Rosin-Arbesfeld R, Cliffe A, Brabletz T, Bienz M. Nuclear export of the APC tumour suppressor controls \u03b2-catenin function in transcription. EMBO J\u20082003; 22: 1101\u201313.","DOI":"10.1093\/emboj\/cdg105"},{"key":"2022061622274478300_B41","doi-asserted-by":"crossref","unstructured":"Yang J, Zhang W, Evans PM, Chen X, He X, Liu C. Adenomatous polyposis coli (APC) differentially regulates \u03b2-catenin phosphorylation and ubiquitination in colon cancer cells. J Biol Chem\u20082006; 281: 17751\u20137.","DOI":"10.1074\/jbc.M600831200"},{"key":"2022061622274478300_B42","doi-asserted-by":"crossref","unstructured":"Lipinski KS, Djeha AH, Ismail T, Mountain A, Young LS, Wrighton CJ. High-level, \u03b2-catenin\/TCF-dependent transgene expression in secondary colorectal cancer tissue. Mol Ther\u20082001; 4: 365\u201371.","DOI":"10.1006\/mthe.2001.0468"},{"key":"2022061622274478300_B43","doi-asserted-by":"crossref","unstructured":"Coen DM, Goldstein DJ, Weller SK. Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir. Antimicrob Agents Chemother\u20081989; 33: 1395\u20139.","DOI":"10.1128\/AAC.33.8.1395"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/20\/10127\/2554630\/10127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/20\/10127\/2554630\/10127.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T21:40:12Z","timestamp":1655415612000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/20\/10127\/526262\/Effective-Treatment-of-Tumors-with-Strong-Catenin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,15]]},"references-count":43,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2006,10,17]]},"published-print":{"date-parts":[[2006,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-2744","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6494400.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6494400","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22364856","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22364856.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,15]]}}}